Navigation Links
Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S.
Date:5/17/2013

JERUSALEM, May 17, 2013 /PRNewswire/ --

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that the United States Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug application(IND) for ORMD-0801, its oral insulin capsule.

"We are very pleased to have the FDA clearance to proceed," stated Nadav Kidron , CEO of Oramed. "The upcoming trial is a major milestone for Oramed and we look forward to continuing to progress ORMD-0801's clinical development in the US."

About ORMD-0801 Oral Insulin

Oramed's ORMD-0801 is an orally ingestible insulin capsule indicated for the early stages of type 2 diabetes, when it can still slow the rate of degeneration of the disease by providing additional insulin to the body and allowing pancreatic respite. Moreover, orally administered insulin has the potential benefit of enhanced patient compliance at this crucial stage as well as the advantage of mimicking insulin's natural location and gradients in the body by first passing through the liver before entering the bloodstream.

For more information on ORMD-0801, the content of which is not part of this press release, please visit http://oramed.com/index.php?page=14

About Oramed Pharmaceuticals

Oramed Pharmaceuticals is a technology pioneer in the field of oral delivery solutions for drugs and vaccines currently delivered via injection. Established in 2006, Oramed's technology is based on over 30 years of research by top research scientists at Jerusalem's Hadassah Medical Center. Oramed is seeking to revolutionize the treatment of diabetes through its proprietary flagship product, an orally ingestible insulin capsule (ORMD-0801) currently initiating Phase
'/>"/>

SOURCE Oramed Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Oramed Pharmaceuticals to Present at the 11th National Life Science & Technology Week ILSI-BIOMED Conference; Tel Aviv, Israel, 2012
2. Oramed Pharmaceuticals Granted Core Technology Patent in New Zealand
3. Oramed Pharmaceuticals to Present at the 12th Annual Diabetes Technology Society Meeting in Bethesda, MD, Nov 8-10, 2012
4. Oramed Pharmaceuticals Completes $5.6 Million Funding to Advance Clinical Trials
5. Oramed Pharmaceuticals Inc. to Webcast, Live, at RetailInvestorConferences.com on February 7th
6. Shares of Oramed Pharmaceuticals Are Approved for Listing on the Nasdaq Capital Market
7. Oramed Pharmaceuticals to Present at the 4th Annual Drug Delivery & Formulation Summit in Berlin
8. Oramed Pharmaceuticals Granted Japanese Patent for its Core Technology in Oral Delivery of Proteins
9. Oramed Submits New IND Application for Oral Insulin Trial in the US
10. Oramed Pharmaceuticals Appoints New Chief Operating Officer and VP of Business Development
11. Oramed Pharmaceuticals Chosen to Present at the 5th International Congress on Prediabetes and the Metabolic Syndrome in Vienna, Austria; April 18-20, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... , Aug. 19, 2014  Cardiva Medical, Inc. ... tranches of a $16.5 million Series 3 private equity ... GE Capital. The Company will use the proceeds of ... to expand commercial efforts for its VASCADE® Vascular Closure ... Investing in Series 3 private equity ...
(Date:8/19/2014)... , August 19, 2014 ... a clinical-stage pharmaceutical company focused on the development ... the Intellectual Property Department of Spain ... its invention, titled "Methods and Compositions for Oral ... Oramed Pharmaceuticals is a technology pioneer ...
(Date:8/19/2014)... MENLO PARK, Calif. , Aug. 19, 2014 /PRNewswire/ ... announced today a protocol amendment to allow for expanded dosing ... U.S. Food and Drug Administration (FDA) and that a new ... at three clinical trial sites in the United ... of US$2.9 million have been raised through warrant exercise in ...
Breaking Medicine Technology:Cardiva Medical, Inc. Announces Completion of the first two tranches of Series 3 Private Equity Financing and the Closing of a Senior Secured Debt Facility with GE Capital 2Oramed Granted Patent in Spain for Oral Administration of Insulin 2Oramed Granted Patent in Spain for Oral Administration of Insulin 3DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 2DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 3DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 4DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 5DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 6DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 7
... R.I., May 19, 2011 CVS Caremark Corporation (NYSE: ... President and Chief Executive Officer, will be making a ... Global Consumer Conference on May 25, 2011. Mr. Merlo ... (Logo: http://photos.prnewswire.com/prnh/20090226/NE75914LOGO) An audio webcast of ...
... 2011 Two studies published in Digestive ... for performing the standard upper endoscopy examination done on over ... of pre-cancerous cells in the esophagus by over 40 percent. ... 25 years, making it the fastest growing form of cancer ...
Cached Medicine Technology:Improved Endoscopy Method Increases Detection of Esophageal Pre-Cancer by Over 40 Percent 2Improved Endoscopy Method Increases Detection of Esophageal Pre-Cancer by Over 40 Percent 3Improved Endoscopy Method Increases Detection of Esophageal Pre-Cancer by Over 40 Percent 4
(Date:8/20/2014)... Kowa Optimed returns after a short hiatus to ... SL-17 portable slit lamp. , The SL-17 has been ... by an illuminated thumb wheel for easy adjustments even ... AAA rechargeable and dry cell batteries, which is an ... specifically for the device. The new Sl-17 base design ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 Riverside Health ... Dameron , who joined its Warsaw Medical Arts team ... specialized in Family Medicine, is accepting new patients. , ... of Medicine, completed his residency at the Mountain Area ... to Virginia. , “I really like the rural aspect ...
(Date:8/20/2014)... 20, 2014 This agreement will ... software defined networking, high availability cloud enablement, service, ... Resellers, while allowing OPEN-V to sell storageFOUNDRY’s expanding ... to work with OPEN-V on this distribution agreement ... manager distribution channels at storageFOUNDRY. "Nautilus is a ...
(Date:8/19/2014)... As moms and dads prepare their children to go back ... routine of dropping their little ones off at daycare with ... encourages them to use the opportunity to implement a new ... explains, “Kids have small tummies, short attention spans, and a ... handouts, use snack time as another daily opportunity to incorporate ...
(Date:8/19/2014)... (PRWEB) August 20, 2014 Midtown Dentistry in ... amalgam-free dental office. All patients with cavities, or with ... latest white fillings that can safely repair and restore teeth. ... the very latest materials, all of which are completely amalgam ... safe for use by the FDA for adults and children ...
Breaking Medicine News(10 mins):Health News:Kowa Optimed (Booth MS13043) to Debut New Portable Slit Lamp at 2014 Vision Expo West in Las Vegas, Nevada 2Health News:Riverside Warsaw Medical Arts’ Dr. William Dameron Accepting New Patients 2Health News:storageFOUNDRY and Open-V OzoneStack Announce Bilateral Distribution Agreement 2Health News:storageFOUNDRY and Open-V OzoneStack Announce Bilateral Distribution Agreement 3Health News:Child Nutritionist Kristen Yarker Wants Parents to Rethink Kids’ Snacks This Fall 2Health News:Child Nutritionist Kristen Yarker Wants Parents to Rethink Kids’ Snacks This Fall 3Health News:Midtown Dentistry Announces It Is Now an Amalgam-Free Office 2
... ... Save Lives in Healthcare Facilities and for Senior Care at Home. , ... (PRWEB) January 26, 2010 -- New inexpensive technologies ... effect of falls particularly in the population now approaching 60 and above. New personal use ...
... ... Cancer Care Delivery System , ... Washington, DC (Vocus) January 26, 2010 -- Community oncologists nationwide, under the ... urge President Obama and lawmakers to reverse drastic cuts in reimbursement for cancer care ...
... , Jan. 26 Milliman Care Guidelines LLC, ... that help health plans, hospitals and other clients optimize the ... software.   , The Care Guidelines promote quality ... on annually updated evidence, thus enabling informed and consistent clinical ...
... ... launched three new document scanners with rated speeds up to 60 images per minute ... models include a 2-Year manufacturer’s warranty, BulletScan Manager Software, and ABBYY FineReader® ... ...
... ... they are now offering Trek’s Ride+ electric assist bikes to their guests. By being one of ... opening up a new world of cycling vacations to a wider range of riders. Now anyone ... ...
... OAK BROOK, Ill. Preoperative computed tomography (CT) may ... with suspected acute appendicitis, according to a new study ... Radiology . "We found that rising utilization of ... in CT technology, coincided with a significant decrease in ...
Cached Medicine News:Health News:Medical Nurse Training, Inc and SaferFalls.com Announce New Products/Technologies to Save Lives in Healthcare Facilities and for Senior Home Care. 2Health News:Medical Nurse Training, Inc and SaferFalls.com Announce New Products/Technologies to Save Lives in Healthcare Facilities and for Senior Home Care. 3Health News:Community Oncologists Launch Petition to Stop Drastic Cancer Care Cuts 2Health News:Community Oncologists Launch Petition to Stop Drastic Cancer Care Cuts 3Health News:Milliman Care Guidelines Offers Online Interrater Reliability Tool and Training 2Health News:Milliman Care Guidelines Offers Online Interrater Reliability Tool and Training 3Health News:Milliman Care Guidelines Offers Online Interrater Reliability Tool and Training 4Health News:iVina Expands BulletScan Document Scanner Product Line Powered by ABBYY FineReader Technology 2Health News:iVina Expands BulletScan Document Scanner Product Line Powered by ABBYY FineReader Technology 3Health News:iVina Expands BulletScan Document Scanner Product Line Powered by ABBYY FineReader Technology 4Health News:Trek Travel Introduces Trek's Ride+ Electric Assist Bikes to Cycling Vacations 2Health News:Preoperative CT useful for younger women with suspected appendicitis 2
... to the National Academy of ... use of cardiac markers in ... is definitive of acute myocardial ... assay was designed for rapid ...
A fluorogenic enzyme-linked immunoassay (ELISA) for the quantitative measurement of myoglobin in human serum or plasma aiding in the diagnosis of acute myocardial infarction (AMI). Features : Dry che...
Clinical marker immunoassay kit for detection of Myoglobin....
AxSYM Myoglobin is a Microparticle Enzyme Immunoassay (MEIA) for the quantitative determination of myoglobin in human serum or plasma on the AxSYM System....
Medicine Products: